Definium Therapeutics (DFTX) Prepaid Assets (2020 - 2026)
Definium Therapeutics (DFTX) reported Prepaid Assets of $7.1 million for Q1 2026, down 22.88% year-over-year from $9.3 million in Q1 2025, and down 7.58% on a QoQ basis from $7.7 million in Q4 2025.
Definium Therapeutics (DFTX) has 7 years of Prepaid Assets data on file, last reported at $7.1 million in Q1 2026.
- Quarterly Prepaid Assets fell 22.88% year-over-year to $7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.1 million (down 22.88% YoY) and the FY2025 annual result came in at $7.7 million, down 1.93% from the prior year.
- Prepaid Assets retreated to $7.1 million in Q1 2026 per DFTX's latest filing, from $7.7 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $9.3 million in Q1 2025 and bottomed at $1.8 million in Q3 2022.
- The 5-year median for Prepaid Assets is $4.1 million (2024), against an average of $4.8 million.
- The widest annual swing landed in 2022, when Prepaid Assets jumped 529.66%; it then dropped 22.88% in 2026.
- Tracing DFTX's Prepaid Assets over 5 years: stood at $3.9 million in 2022, then climbed by 6.52% to $4.2 million in 2023, then surged by 89.04% to $7.9 million in 2024, then retreated by 1.93% to $7.7 million in 2025, then slipped by 7.58% to $7.1 million in 2026.
- Per Business Quant, the three latest DFTX Prepaid Assets figures stand at $7.1 million (Q1 2026), $7.7 million (Q4 2025), and $6.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.14 Mn |
| Dec 31, 2025 | 7.73 Mn |
| Sep 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 6.14 Mn |
| Mar 31, 2025 | 9.26 Mn |
| Dec 31, 2024 | 7.88 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | 3.14 Mn |
| Dec 31, 2023 | 4.17 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | 3.91 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 3.17 Mn |
| Mar 31, 2022 | 2.76 Mn |
| Dec 31, 2021 | 3.68 Mn |
| Sep 30, 2021 | 290,000.00 |
| Jun 30, 2021 | 1.46 Mn |
| Mar 31, 2021 | -1.42 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Sep 30, 2020 | -601,000.00 |
| Jun 30, 2020 | -795,000.00 |
| Mar 31, 2020 | 2.30 Mn |